Your browser doesn't support javascript.
loading
Highlights From AHA 2023-New Risk Calculator, Semaglutide and CVD, and More.
Abbasi, Jennifer.
JAMA ; 330(23): 2237-2240, 2023 12 19.
Article in En | MEDLINE | ID: mdl-37991804
This Medical News article discusses late-breaking science and other clinical highlights from the American Heart Association's Scientific Sessions meeting.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Glucagon-Like Peptide-1 Receptor Agonists Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Glucagon-Like Peptide-1 Receptor Agonists Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2023 Document type: Article Country of publication: